Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa.

Saved in:
Bibliographic Details
Title: Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa.
Authors: Downs LO; Nuffield Department of Medicine, University of Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Delphin M; The Francis Crick Institute, 1 Midland Road, London, UK., van Schalkwyk M; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa., Hugo S; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa., Lumley SF; Nuffield Department of Medicine, University of Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Waddilove E; The Francis Crick Institute, 1 Midland Road, London, UK., Wang T; Nuffield Department of Medicine, University of Oxford, UK., Martin J; Department of Hepatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., de Lara C; Nuffield Department of Medicine, University of Oxford, UK., Babbs A; Nuffield Department of Medicine, University of Oxford, UK., Andersson MI; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Glashoff RH; Division of Medical Microbiology & Immunology, Stellenbosch University and National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Ansari MA; Nuffield Department of Medicine, University of Oxford, UK., Agarwal K; Institute of Liver Studies, King's College Hospital, London, UK., Dusheiko G; Institute of Liver Studies, King's College Hospital, London, UK., Taljaard J; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa., Preiser W; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Barnes E; Nuffield Department of Medicine, University of Oxford, UK; Department of Hepatology and Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Kelly G; The Francis Crick Institute, 1 Midland Road, London, UK., Carey I; Institute of Liver Studies, King's College Hospital, London, UK., Shimakawa Y; Institut Pasteur, Université Paris Cité, Unité d'Épidémiologie des Maladies Émergentes, Paris, France., Maponga TG; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Matthews PC; The Francis Crick Institute, 1 Midland Road, London, UK; Department of Infectious Diseases, University College London Hospitals, Euston Road, London, UK; Division of Infection and Immunity, University College London, Gower Street, London, UK. Electronic address: Philippa.matthews@crick.ac.uk.
Source: The Journal of infection [J Infect] 2025 Sep; Vol. 91 (3), pp. 106601. Date of Electronic Publication: 2025 Aug 21.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2742
DOI:10.1016/j.jinf.2025.106601